Mon, April 3, 2023

Matthew Harrison Maintained (BLUE) at Sell with Decreased Target to $3 on, Apr 3rd, 2023

Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Sell with Decreased Target from $4 to $3 on, Apr 3rd, 2023.

Matthew has made no other calls on BLUE in the last 4 months.



There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 3 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jason Gerberry of "B of A Securities" Maintained at Hold with Decreased Target to $6 on, Thursday, March 30th, 2023
  • Luca Issi of "RBC Capital" Reiterated at Hold and Held Target at $8 on, Thursday, March 30th, 2023
  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $8 on, Monday, January 23rd, 2023


This is the rating of the analyst that currently disagrees with Matthew


  • Jack Allen of "Baird" Initiated at Buy and Held Target at $10 on, Tuesday, March 7th, 2023